Trial · NCT03364335
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage Body Weight Change | Baseline to Day 168 | The percentage body weight change from baseline to Day 168 was evaluated. |
| Secondary | Change in Absolute Body Weight | Baseline to Day 168 | The change in absolute body weight from baseline to day 168 was evaluated. |
| Secondary | Change in Percentage of Patients With ≥5% Body Weight Loss | Baseline to Day 168 | The number of patients with ≥5% body weight loss in each group was assessed from baseline to day 168. |
| Secondary | Change in Waist Circumference | Baseline to Day 168 | The change in waist circumference by using a tape measure across the mid-section was evaluated in subjects from baseline to day 168. |
| Secondary | Change in Total Cholesterol | Baseline to Day 168 | Changes in total cholesterol was examined by standard blood chemistry. |
| Secondary | Change in HDL Cholesterol | Baseline, Day 168 | Changes were measured in HDL cholesterol from Baseline to day 168 by standard blood chemistry. |
| Secondary | Change in LDL Cholesterol | Baseline, 168 days | Changes in LDL Cholesterol was measured by standard blood chemistry from baseline to day 168. |
| Secondary | Change in Triglycerides | Baseline, Day 168 | The change in triglycerides was evaluated by standard blood chemistry in subjects from Baseline to Day 168. |
| Secondary | Change in Plasma Glucose | Baseline to Day 168 | Change in plasma glucose was examined through standard fasting blood chemistry. |
| Secondary | Change in Hemoglobin A1c (HbA1c) | Baseline, Day 168 | Change in Hemoglobin A1c was assessed in the subjects from baseline to day 168. |
| Secondary | Change in Diastolic Blood Pressure | Baseline to Day 168 | Diastolic blood pressure was measured by standard blood pressure monitor. |
| Secondary | Change in Systolic Blood Pressure | Baseline, Day 168 | Change in Systolic blood pressure was assessed in patients from baseline to Day 168 |
| Secondary | Change in Inflammatory Markers | Baseline to Day 168 | hs-C-Reactive Protein (CRP) levels was examined by standard blood chemistry. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03364335/registered